Maestro Health Investors

27 investors on Angel Roster list Maestro Health in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Maestro Health can appear together.

Investors listed
27
With verified email
37%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 27 Maestro Health investors

The most complete profiles first. Showing 27 of 27.

  • Allen MillerVerified

    Venture Capital, Private Equity Firm, Micro VC · United States

    Series BHealth CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 53 more

    Verified email available

  • David BlackVerified

    Venture Capital, Investor · United States

    Series BHealth CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 52 more

    Verified email available

  • Eliza AdamsVerified

    Venture Capital, Private Equity Firm, Micro VC · United States

    Series BHealth CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 52 more

    Contact details available

  • Eugene HillVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Verified email available

  • Jack KenneyVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Paul LaVioletteVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more

    Verified email available

  • Tom FlynnVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Vig ChandramouliVerified

    Venture Capital, Private Equity Firm, Micro VC · United States

    Series BHealth CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 52 more

    Verified email available

  • Andy SmithVerified

    Venture Capital, Private Equity Firm, Micro VC · United States

    Health CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 52 more

    Verified email available

  • Brigitte TondreauVerified

    Venture Capital · United States

    Health CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 52 more

    Verified email available

  • Elizabeth Blake SchwertVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Mike RossVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Verified email available

  • Billy Deitch

    Venture Capital, Private Equity Firm, Micro VC · United States

    Series BHealth CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 52 more

    Contact details available

  • Gregory Madden

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more

    Contact details available

  • Houman Ashrafian

    Venture Capital, Investor · United Kingdom

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Contact details available

  • Jenn Adams

    Venture Capital, Investor · United States

    Series BHealth CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 52 more

    Contact details available

  • Michael Balmuth

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more

    Contact details available

  • Nancy G. Brown

    Venture Capital, Private Equity Firm, Micro VC · United States

    Series BHealth CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 53 more

    Contact details available

  • Oivind Lorentzen

    Venture Capital, Private Equity Firm, Micro VC · United States

    Series BHealth CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 52 more

    Contact details available

  • Zeke Emanuel

    Venture Capital, Investor · United States

    Series BHealth CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 52 more

    Contact details available

  • Andrew Adams

    Venture Capital, Private Equity Firm, Micro VC · United States

    Health CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 52 more

    Contact details available

  • Brent Faduski

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Carl Culicchia

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more

    Contact details available

  • Daniel P Petrozzo

    Venture Capital · United States

    Health CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 58 more

    Contact details available

  • Leah Scanlan

    Venture Capital, Private Equity Firm, Micro VC · United States

    Health CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 52 more

    Contact details available

  • Matt Streisfeld

    Venture Capital, Private Equity Firm, Micro VC · United States

    Health CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 52 more

    Contact details available

  • Michelle Daubar

    Venture Capital, Private Equity Firm, Micro VC · United States

    Health CareWearablesHospitalsE-commerce

    Portfolio: CLARA analytics, Kasisto, Quartet Health, Notable and 52 more

    Contact details available

Frequently asked questions

How many Maestro Health investors are on Angel Roster?

Angel Roster lists 27 Maestro Health investors. 10 of them (37%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (27), Private Equity Firms (15) and Micro VC Firms (11). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Maestro Health investors invest in?

Among those that list a stage, the most common are Series B (9) and Seed (7).

Where are Maestro Health investors based?

Most are based in the United States (26) and the United Kingdom (1).

Which companies have Maestro Health investors backed?

The most-backed portfolio companies among them are Cerebral (16), Wisetack (16), Notable (16), Circulo Health (16) and Therapy Brands (16).

How do I contact Maestro Health investors?

Create a free Angel Roster account to search and filter all 27, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.